Aptevo Therapeutics Inc. Announces Closing of Previously Announced $5 Million Public Offering
05.08.2023 - SEATTLE, WA / ACCESSWIRE / August 4, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ('Aptevo' or the 'Company'), a clinical stage biotechnology company focused on developing novel immuno-oncology therapeutics, today announced the closing of its ...